Find Research Projects — Monash University

Newton, P., Burry, M., Pettit, C., Grodach, C., Morrison, G., Keller, J., Murray, S., Haeussler, M., White, M., Urich, C., Dia, H., Rohl, A., Liu, X., Kenway, S. J. & Gibbes, B.

17/04/19 → 16/04/20

Project: Research

A Randomized, Controlled, Open-Label, Rater-Blinded, Phase 3b Study of the Efficacy, Safety, and Tolerability of 6-Week Extended Interval Dosing of Natalizumab (BG00002) in Subjects With Relapsing-Remitting Multiple Sclerosis Switching from Treatment with 4-Week Natalizumab Standard Interval Dosing (SID) in Relation to Continued SID Treatment.

Van Der Walt, A.

16/04/19 → 31/12/24

Project: Research

An Open-Label Study to Assess The Efficacy and Safety of LM011 In Subjects Diagnosed With Non-Alcoholic Steatohepatitis (NASH).

Roberts, S.

16/04/19 → 31/12/19

Project: Research

PDS: Patties Design Sprint: Freezer

Norris, A. & Achariya, A.

16/04/19 → 23/05/19

Project: Consultancy

AI for Law Enforcement & Community Safety

Wilson, C.

Australian Federal Police (AFP)

15/04/19 → 14/04/22

Project: Research

A Phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of Etrolizumab as an induction and maintenance treatment for patients with moderately to severely active Crohn’s Disease

Moore, G.

15/04/19 → 14/04/24

Project: Research

Youth in the city: one place many cultures

Wilson, R., Ricatti, F., Dutto, M., Iaconesi, S., Persico, O. & Simeone, L.

15/04/19 → 31/05/20

Project: Research

Noxopharm 2019 studies

Trevaskis, N.

15/04/19 → 15/04/20

Project: Other

Austin Health MDS Registry service agreement

Wood, E.

15/04/19 → 14/04/20

Project: Consultancy

Statistical modelling of systolic and diastolic blood pressure and lipids among patients with type 1 diabetes

Earnest, A.

10/04/19 → 22/05/19

Project: Consultancy

CoDev Townhouse Model: Affordable, high quality housing design

Bertram, N., Khor, L. & Sainsbury, O.

9/04/19 → 30/06/19

Project: Research

Understanding current trends in motorcycle crashes relevant to Ride Smart education

Newstead, S., Allen, T. & Mulvihill, C.

Transport Accident Commission (TAC)

8/04/19 → 28/06/19

Project: Research

Cardiorespiratory function as a non-invasive biomarker for detecting seizures with artificial intelligence: Utilising data from long-term patient recordings from an epilepsy monitoring unit

O'Brien, T., Kwan, P., Sivathamboo, S., Perucca, P., Ge, Z., Le, T., Phung, D., Bonnington, P. & Piccenna, L.

8/04/19 → 8/04/20

Project: Research

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Tolerability of GRF6021 Infusions in Subjects with Parkinson's Disease and Cognitive Impairment.

Bertram, K. & O'Brien, T.

8/04/19 → 30/04/20

Project: Research

Supporting Australian Schools to Build International Engagement

Parr, G., Murray, D. & Connelly, S.

8/04/19 → 21/06/19

Project: Research

A Randomized, double-blind, placebo controlled phase 3 study to evaluate the efficacy and safety of QPI-1002 for the prevention of major adverse kidney events (MAKE) in subjects at high risk for acute kidney injury (AKI) following cardiac surgery.

Udy, A. & Young, M.

8/04/19 → 31/12/24

Project: Research

Maker workshops for all: including people with disabilities

Ellis, K., Morgan, M. & Crouch, L.

5/04/19 → 22/09/19

Project: Research

A Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Study of ANAVEX2-73 in patients with Rett Syndrome.

O'Brien, T.

5/04/19 → 31/12/19

Project: Research

A Phase III Randomised, Double-Blind Trial To Evaluate The Effect Of 12 Weeks Treatment Of Once Daily Empagliflozin 10mg Compared With Placebo On Exercise Ability And Heart Failure Symptoms, In Patients With Chronic Heart Failure With Preserved Ejection Fraction (Hfpef) (EMPERIAL - Preserved)

Nicholls, S.

4/04/19 → 3/04/24

Project: Research

A phase IB open-label, dose-escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with androgen deprivation therapy and other agents in subjects with castrate resistant prostate cancer (CRPC)

Parakh, S.

4/04/19 → 3/04/24

Project: Research

Collaborative Study Agreement with the University of Wollongong

Charman, S. & Powell, A.

4/04/19 → 31/12/21

Project: Research

A Phase III Randomised, Double-Blind Trial To Evaluate The Effect Of 12 Weeks Treatment Of Once Daily Empaglifozin 10mg Compared With Placebo On Exercise Ability And Heart Failure Symptoms, In Patients With Chronic Heart Failure With Reduced Ejection Fraction (Hfref) (EMPERIAL – Reduced)

Nicholls, S.

4/04/19 → 3/04/24

Project: Research